Peter Stanko

653 total citations
14 papers, 508 citations indexed

About

Peter Stanko is a scholar working on Cardiology and Cardiovascular Medicine, Endocrine and Autonomic Systems and Behavioral Neuroscience. According to data from OpenAlex, Peter Stanko has authored 14 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 2 papers in Endocrine and Autonomic Systems and 2 papers in Behavioral Neuroscience. Recurrent topics in Peter Stanko's work include Heart rate and cardiovascular health (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Stress Responses and Cortisol (2 papers). Peter Stanko is often cited by papers focused on Heart rate and cardiovascular health (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Stress Responses and Cortisol (2 papers). Peter Stanko collaborates with scholars based in Slovakia, Czechia and United States. Peter Stanko's co-authors include Douglas C. Russell, Timothy R. DeGrado, Charles K. Stone, Robert J. Nickles, Michael D. Taylor, Michael Taylor, Robert J. Nickles, Fedor Šimko, Kristina Krajcirovicova and Silvia Aziriova and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Peter Stanko

12 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Stanko Slovakia 7 336 138 119 82 45 14 508
Prasad Gunaruwan United Kingdom 9 328 1.0× 60 0.4× 128 1.1× 182 2.2× 64 1.4× 13 557
Isidore C Okere United States 14 445 1.3× 66 0.5× 311 2.6× 354 4.3× 33 0.7× 16 766
Jim Gamble Canada 2 261 0.8× 70 0.5× 300 2.5× 152 1.9× 52 1.2× 2 536
Oleg E. Osadchii Denmark 19 696 2.1× 35 0.3× 521 4.4× 67 0.8× 62 1.4× 54 999
Chun Hong Shao United States 10 277 0.8× 26 0.2× 167 1.4× 68 0.8× 57 1.3× 14 492
Martine Desrois France 12 332 1.0× 129 0.9× 228 1.9× 166 2.0× 110 2.4× 32 669
Yosuke Nakatani Japan 17 700 2.1× 54 0.4× 116 1.0× 42 0.5× 70 1.6× 80 929
Petri Kaheinen Finland 13 408 1.2× 21 0.2× 178 1.5× 72 0.9× 63 1.4× 19 711
Eirik Qvigstad Norway 20 619 1.8× 32 0.2× 674 5.7× 112 1.4× 63 1.4× 43 1.1k
P. Y. Hatt France 15 509 1.5× 73 0.5× 235 2.0× 81 1.0× 51 1.1× 38 697

Countries citing papers authored by Peter Stanko

Since Specialization
Citations

This map shows the geographic impact of Peter Stanko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Stanko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Stanko more than expected).

Fields of papers citing papers by Peter Stanko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Stanko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Stanko. The network helps show where Peter Stanko may publish in the future.

Co-authorship network of co-authors of Peter Stanko

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Stanko. A scholar is included among the top collaborators of Peter Stanko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Stanko. Peter Stanko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Aziriova, Silvia, Peter Stanko, Kristina Repova, et al.. (2025). Effect of Sacubitril/Valsartan, Ivabradine, and Captopril on Anxiety-like Behavior in Spontaneously Hypertensive Rats. International Journal of Molecular Sciences. 26(22). 10905–10905. 1 indexed citations
2.
Šimko, Fedor, Peter Stanko, Kristina Repova, et al.. (2024). Effect of sacubitril/valsartan on the hypertensive heart in continuous light-induced and lactacystin-induced pre-hypertension: Interactions with the renin-angiotensin-aldosterone system. Biomedicine & Pharmacotherapy. 173. 116391–116391. 2 indexed citations
3.
Stanko, Peter, Kristina Repova, Tomáš Baka, et al.. (2024). Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease. Biomedicines. 12(4). 733–733. 6 indexed citations
4.
Smieško, Martin, et al.. (2024). Tongue Ultrasonography in the Screening of Severe Obstructive Sleep Apnea Syndrome—Promising Potential for Overloaded Sleep Centers. SHILAP Revista de lepidopterología. 12(12). 330–330.
5.
Baka, Tomáš, Peter Stanko, Kristina Repova, et al.. (2023). Ivabradine curbs isoproterenol-induced kidney fibrosis. General Physiology and Biophysics. 42(2). 209–215. 1 indexed citations
6.
Repova, Kristina, Peter Stanko, Tomáš Baka, et al.. (2022). Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril. Frontiers in Pharmacology. 13. 978337–978337. 7 indexed citations
7.
Repova, Kristina, Tomáš Baka, Kristina Krajcirovicova, et al.. (2022). Melatonin as a Potential Approach to Anxiety Treatment. International Journal of Molecular Sciences. 23(24). 16187–16187. 40 indexed citations
10.
Stanko, Peter, Tomáš Baka, Kristina Repova, et al.. (2020). Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension. Frontiers in Medicine. 7. 18 indexed citations
11.
Repova, Kristina, Silvia Aziriova, Tomáš Baka, et al.. (2019). Lisinopril reverses behavioural alterations in spontaneously hypertensive rats. General Physiology and Biophysics. 38(3). 265–270. 3 indexed citations
12.
Adamcová, Michaela, Tomáš Baka, Eva Doleželová, et al.. (2019). Relations between markers of cardiac remodelling and left ventricular collagen in an isoproterenol-induced heart damage model.. PubMed. 70(1). 10 indexed citations
13.
Taylor, Michael D., Timothy R. DeGrado, Douglas C. Russell, et al.. (2001). An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.. PubMed. 42(1). 55–62. 212 indexed citations
14.
Taylor, Michael, Timothy R. DeGrado, Douglas C. Russell, et al.. (2001). Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure. Circulation. 103(20). 2441–2446. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026